Results from TANGO II Comparing Meropenem 2 g/Vaborbactam 2 g Infused

Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date. - Document - Gale OneFile: Health and Medicine

Clinical evaluation of meropenem-vaborbactam for UTI

Rodrigo BURGOS, Clinical Associate Professor, Doctor of Pharmacy, University of Illinois at Chicago, IL, UIC, Department of Pharmacy Practice

Rodrigo BURGOS, Clinical Associate Professor, Doctor of Pharmacy, University of Illinois at Chicago, IL, UIC, Department of Pharmacy Practice

6310 PDFs Review articles in CLINICAL EVALUATION

Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date. - Document - Gale OneFile: Health and Medicine

PDF) Meropenem-Vaborbactam vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection

PDF) Meropenem-Vaborbactam vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection

6310 PDFs Review articles in CLINICAL EVALUATION

Rodrigo BURGOS, Clinical Associate Professor, Doctor of Pharmacy, University of Illinois at Chicago, IL, UIC, Department of Pharmacy Practice

11960 PDFs Review articles in BACTERIAL PNEUMONIA

11960 PDFs Review articles in BACTERIAL PNEUMONIA

PDF) Meropenem-Vaborbactam vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection